Report overview
This report aims to provide a comprehensive presentation of the global market for Biotechnological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnological Drugs. This report contains market size and forecasts of Biotechnological Drugs in global, including the following market information:
Global Biotechnological Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Biotechnological Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Genetically Engineered Drugs Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Biotechnological Drugs include 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical, Cadila Healthcare, Celgen Biopharma, Celltrion, Dr Reddy?s and GeneScience Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biotechnological Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biotechnological Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Biotechnological Drugs Market Segment Percentages, by Type, 2022 (%)
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Global Biotechnological Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Biotechnological Drugs Market Segment Percentages, by Application, 2022 (%)
Tumor
Autoimmune Disease
Other
Global Biotechnological Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Biotechnological Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biotechnological Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biotechnological Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy?s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biotechnological Drugs, market overview.
Chapter 2: Global Biotechnological Drugs market size in revenue.
Chapter 3: Detailed analysis of Biotechnological Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biotechnological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
